CoChat

SPLIT-FACE COMPARATIVE ANALYSIS OF MICRO-NEEDLING WITH TRANEXAMIC ACID VS VITAMIN C SERUM IN MELASMA

Open access
Raza, Musarrat Hussain, Iftikhar, Nadia, Anwar, Ayesha, Mashhood, Asher Ahmed, Tariq, Shahan, Hamid, Muhammad Ammar Bin · 2022 · Journal of Ayub Medical College Abbottabad

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: Melasma is a very common skin problem that is much more prevalent in women. In our society, it results in many psycho-social implications and eventually leads to an impaired quality of life. Many treatment modalities have been developed for it. However, in recent years resistant forms of melasma have emerged that are unresponsive to the usual first line treatment options. Thus, this study is being conducted to explore new treatment modalities for this disease by using micro-needling with vitamin C and tranexamic acid. Methods: Thirty patients participated in this non-randomized clinical trial including 11 males and 19 females. All patients received Tranexamic acid via micro-needling on right side of the face and Vitamin C on the left side. A total of three biweekly sessions were performed. Patients’ response was evaluated at week 2, 4 and 6 on the basis of Physician Global Assessment, Patient Global Assessment, modified Melasma Area Severity Index and clinical assessment. Paired sample t-tests were used to calculate the difference in the means of two groups at 2, 4 and 6 weeks and p-value of <0.05 was considered significant. Results: After first session, there was more improvement observed with tranexamic acid. At the end of 6 weeks, modified Melasma Area Severity Index, Physician Global Assessment and Patient Global Assessment showed significant improvement with both tranexamic acid and vitamin C. However, the difference between them was not statistically significant (p>0.05). Conclusion: Both Tranexamic acid and Vitamin C are potent therapies for melasma as an adjuvant to micro-needling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.55519/jamc-01-9840

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 9

  1. Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. J Am Acad Dermatol 2011;65(4):699-714.
  2. Legarda-Montinola F. Classification and Clinical Presentations of Melasma in Brown Skin. In: Melasma and Vitiligo in Brown Skin. Springer, New Delhi. 2017; p.33-40.
  3. Taylor MB, Yanaki JS, Draper DO, Shurtz JC, Coglianese M. Successful short term and long-term treatment of melasma and post-inflammatory hyperpigmentation using Vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen. J Drugs Dermatol 2013;12(1):45-50.
  4. Maeda K, Tomita Y. Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium. J Health Sci 2007;53(4):389-96.
  5. Babbush KM, Babbush RA, Khachemoune A. The Therapeutic Use of Antioxidants for Melasma. J Drugs Dermatol 2020;19(8):788-92.
  6. Cohen B, Elbuluk N. Microneedling in skin of color: A review of uses and efficacy. J Am Acad Dermatol 2016;74:348-55.
  7. Lima E. Microneedling in facial recalcitrant melasma: Report of a series of 22 cases. An Bras Dermatol 2015;90(6):919-21.
  8. Ebrahim HM, Abdelshafy AS, Khattab F, Gharib K. Tranexamic Acid for Melasma Treatment: A Split-Face Study. Dermatol Surg 2020;46(11):e102-7.
  9. Zhao H, Li M, Zhang X, Li L, Yan Y, Wang B. Comparing the efficacy of Myjet-assisted tranexamic acid and vitamin C in treating melasma: A split-face controlled trial. J Cosmet Dermatol 2020;19(1):47-54. Submitted: July 7, 2021 Revised: August 5, 2021 Accepted: August 8, 2021 Address for Correspondence:

Cited by

Metadata

Authors
Raza, M. H., Iftikhar, N., Anwar, A., Mashhood, A. A., Tariq, S., & Hamid, M. A. B.
Affiliations
Pakistan Army (PK)
Venue
Journal of Ayub Medical College Abbottabad
Published
2022-01-01
Volume
34
Issue
1
Pages
169-172
ISSN
  • 1025-9589 (ISSN-L)
  • 1819-2718
OpenAlex
W4224433987
Cited by
17
References
8
Citations by year
2026: 3 · 2025: 5 · 2024: 6 · 2023: 3
FWCI
3.42
Type
journal article
Language
en
Open access
Locations
  • Journal of Ayub Medical College Abbottabad (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
Keywords
melasma, microneedling, tranexamic acid, split-face comparison, Melasma Area and Severity Index, adjuvant therapy, hyperpigmentation treatment
MeSH terms
Ascorbic Acid, Female, Humans, Male, Melanosis, Quality of Life, Tranexamic Acid, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.